Hyperkalemia Drugs Market- 38% of Growth to Originate from North America| |Evolving Opportunities with AdvaCare International & Ardelyx Inc |17000+ Technavio Reports

For more insights on the market share of various regions - Download a free sample now!

Market Dynamics

Factors such as growing cases of chronic diseases, the growing use of various therapeutics, and the increasing prevalence of hyperkalemia will drive the growth of the Hyperkalemia Drugs Market. However, poor diagnosis might hamper the market growth. The holistic analysis of the drivers & challenges will help in deducing end goals and refining marketing strategies to gain a competitive edge.

Company Profiles

The hyperkalemia drugs market is concentrated and the vendors are deploying organic and inorganic growth strategies to compete in the market. The hyperkalemia drugs market report includes information on the product launches, sustainability, and prospects of leading vendors including AdvaCare International, Ardelyx Inc., AstraZeneca Plc, CytoSorbents Corp., KVK Tech Inc., Sanofi SA, Steadfast MediShield Pvt. Ltd., and Vifor Pharma Management Ltd.

Few companies with their key offerings

• AdvaCare International - The company offers hyperkalemia drugs as relief in antagonizing the cardiac toxicity provided the patient is not receiving digitalis therapy, under the brand name CalcoCare.
• Ardelyx Inc. - The company offers a hyperkalemia drug that targets potassium secretion through the lumen of the gut, which is still in development under RDX013.
• AstraZeneca Plc - The company offers a hyperkalemia drug that provides rapid and sustained potassium control for patients, under the brand name Lokelma.
• CytoSorbents Corp. - The company offers a hyperkalemia drug designed to treat cases of moderate to severe hyperkalemia where dialysis is not available, under the brand name Kontrol.
• KVK Tech Inc. - The company offers hyperkalemia drugs such as sodium polystyrene sulfonate powder, under the brand name Kayexalate.
• To know about all major vendors with their key offerings - Download a free sample now!

Competitive Analysis

The competitive scenario provided in the hyperkalemia drugs market report analyzes, evaluates, and positions companies based on various performance indicators. Some of the factors considered for this analysis include the financial performance of companies over the past few years, growth strategies, product innovations, new product launches, investments, growth in market share, etc.

Market Segmentation

• By Type, the market is classified into chronic hyperkalemia and acute hyperkalemia.
• By Geography, the market is classified as North America, Europe, Asia, and the Rest of the World (ROW). 

To know about the contribution of each segment - Download a free sample now!

Related Reports -

• The retinal drugs market size has the potential to grow by USD 6.28 billion from 2020 to 2025, and the market's growth momentum will accelerate at a CAGR of 6.10%. Download a free sample now!
• The schizophrenia drugs market share should rise by USD 957.50 million from 2021 to 2025 at a CAGR of 2.06%. Download a free sample now!

Table of Content

1 Executive Summary

• 1.1 Market overview
• Exhibit 01: Executive Summary – Chart on Market Overview
• Exhibit 02: Executive Summary – Data Table on Market Overview
• Exhibit 03: Executive Summary – Chart on Global Market Characteristics
• Exhibit 04: Executive Summary – Chart on Market by Geography
• Exhibit 05: Executive Summary – Chart on Market Segmentation by Type
• Exhibit 06: Executive Summary – Chart on Incremental Growth
• Exhibit 07: Executive Summary – Data Table on Incremental Growth
• Exhibit 08: Executive Summary – Chart on Vendor Market Positioning

2 Market Landscape

• 2.1 Market ecosystem
• Exhibit 09: Parent market
• Exhibit 10: Market Characteristics

3 Market Sizing

• 3.1 Market definition
• Exhibit 11: Offerings of vendors included in the market definition

• 3.2 Market segment analysis
• Exhibit 12: Market segments

• 3.3 Market size 2021

• 3.4 Market outlook: Forecast for 2021-2026
• Exhibit 13: Chart on Global - Market size and forecast 2021-2026 ($ million)
• Exhibit 14: Data Table on Global - Market size and forecast 2021-2026 ($ million)
• Exhibit 15: Chart on Global Market: Year-over-year growth 2021-2026 (%)
• Exhibit 16: Data Table on Global Market: Year-over-year growth 2021-2026 (%)

4 Five Forces Analysis

• 4.1 Five forces summary
• Exhibit 17: Five forces analysis - Comparison between2021 and 2026

• 4.2 Bargaining power of buyers
• Exhibit 18: Chart on Bargaining power of buyers – Impact of key factors 2021 and 2026

• 4.3 Bargaining power of suppliers
• Exhibit 19: Bargaining power of suppliers – Impact of key factors in 2021 and 2026

• 4.4 Threat of new entrants
• Exhibit 20: Threat of new entrants – Impact of key factors in 2021 and 2026

• 4.5 Threat of substitutes
• Exhibit 21: Threat of substitutes – Impact of key factors in 2021 and 2026

• 4.6 Threat of rivalry
• Exhibit 22: Threat of rivalry – Impact of key factors in 2021 and 2026

• 4.7 Market condition
• Exhibit 23: Chart on Market condition - Five forces 2021 and 2026

5 Market Segmentation by Type

• 5.1 Market segments
• Exhibit 24: Chart on Type - Market share 2021-2026 (%)
• Exhibit 25: Data Table on Type - Market share 2021-2026 (%)

• 5.2 Comparison by Type
• Exhibit 26: Chart on Comparison by Type
• Exhibit 27: Data Table on Comparison by Type

• 5.3 Chronic hyperkalemia - Market size and forecast 2021-2026
• Exhibit 28: Chart on Chronic hyperkalemia - Market size and forecast 2021-2026 ($ million)
• Exhibit 29: Data Table on Chronic hyperkalemia - Market size and forecast 2021-2026 ($ million)
• Exhibit 30: Chart on Chronic hyperkalemia - Year-over-year growth 2021-2026 (%)
• Exhibit 31: Data Table on Chronic hyperkalemia - Year-over-year growth 2021-2026 (%)

• 5.4 Acute hyperkalemia - Market size and forecast 2021-2026
• Exhibit 32: Chart on Acute hyperkalemia - Market size and forecast 2021-2026 ($ million)
• Exhibit 33: Data Table on Acute hyperkalemia - Market size and forecast 2021-2026 ($ million)
• Exhibit 34: Chart on Acute hyperkalemia - Year-over-year growth 2021-2026 (%)
• Exhibit 35: Data Table on Acute hyperkalemia - Year-over-year growth 2021-2026 (%)

• 5.5 Market opportunity by Type
• Exhibit 36: Market opportunity by Type ($ million)

6 Customer Landscape

• 6.1 Customer landscape overview
• Exhibit 37: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria

7 Geographic Landscape

• 7.1 Geographic segmentation
• Exhibit 38: Chart on Market share by geography 2021-2026 (%)
• Exhibit 39: Data Table on Market share by geography 2021-2026 (%)

• 7.2 Geographic comparison
• Exhibit 40: Chart on Geographic comparison
• Exhibit 41: Data Table on Geographic comparison

• 7.3 North America - Market size and forecast 2021-2026
• Exhibit 42: Chart on North America - Market size and forecast 2021-2026 ($ million)
• Exhibit 43: Data Table on North America - Market size and forecast 2021-2026 ($ million)
• Exhibit 44: Chart on North America - Year-over-year growth 2021-2026 (%)
• Exhibit 45: Data Table on North America - Year-over-year growth 2021-2026 (%)

• 7.4 Europe - Market size and forecast 2021-2026
• Exhibit 46: Chart on Europe - Market size and forecast 2021-2026 ($ million)
• Exhibit 47: Data Table on Europe - Market size and forecast 2021-2026 ($ million)
• Exhibit 48: Chart on Europe - Year-over-year growth 2021-2026 (%)
• Exhibit 49: Data Table on Europe - Year-over-year growth 2021-2026 (%)

• 7.5 Asia - Market size and forecast 2021-2026
• Exhibit 50: Chart on Asia - Market size and forecast 2021-2026 ($ million)
• Exhibit 51: Data Table on Asia - Market size and forecast 2021-2026 ($ million)
• Exhibit 52: Chart on Asia - Year-over-year growth 2021-2026 (%)
• Exhibit 53: Data Table on Asia - Year-over-year growth 2021-2026 (%)

• 7.6 Rest of World (ROW) - Market size and forecast 2021-2026
• Exhibit 54: Chart on Rest of World (ROW) - Market size and forecast 2021-2026 ($ million)
• Exhibit 55: Data Table on Rest of World (ROW) - Market size and forecast 2021-2026 ($ million)
• Exhibit 56: Chart on Rest of World (ROW) - Year-over-year growth 2021-2026 (%)
• Exhibit 57: Data Table on Rest of World (ROW) - Year-over-year growth 2021-2026 (%)

• 7.7 US - Market size and forecast 2021-2026
• Exhibit 58: Chart on US - Market size and forecast 2021-2026 ($ million)
• Exhibit 59: Data Table on US - Market size and forecast 2021-2026 ($ million)
• Exhibit 60: Chart on US - Year-over-year growth 2021-2026 (%)
• Exhibit 61: Data Table on US - Year-over-year growth 2021-2026 (%)

• 7.8 Germany - Market size and forecast 2021-2026
• Exhibit 62: Chart on Germany - Market size and forecast 2021-2026 ($ million)
• Exhibit 63: Data Table on Germany - Market size and forecast 2021-2026 ($ million)
• Exhibit 64: Chart on Germany - Year-over-year growth 2021-2026 (%)
• Exhibit 65: Data Table on Germany - Year-over-year growth 2021-2026 (%)

• 7.9 Canada - Market size and forecast 2021-2026
• Exhibit 66: Chart on Canada - Market size and forecast 2021-2026 ($ million)
• Exhibit 67: Data Table on Canada - Market size and forecast 2021-2026 ($ million)
• Exhibit 68: Chart on Canada - Year-over-year growth 2021-2026 (%)
• Exhibit 69: Data Table on Canada - Year-over-year growth 2021-2026 (%)

• 7.10 France - Market size and forecast 2021-2026
• Exhibit 70: Chart on France - Market size and forecast 2021-2026 ($ million)
• Exhibit 71: Data Table on France - Market size and forecast 2021-2026 ($ million)
• Exhibit 72: Chart on France - Year-over-year growth 2021-2026 (%)
• Exhibit 73: Data Table on France - Year-over-year growth 2021-2026 (%)

• 7.11 UK - Market size and forecast 2021-2026
• Exhibit 74: Chart on UK - Market size and forecast 2021-2026 ($ million)
• Exhibit 75: Data Table on UK - Market size and forecast 2021-2026 ($ million)
• Exhibit 76: Chart on UK - Year-over-year growth 2021-2026 (%)
• Exhibit 77: Data Table on UK - Year-over-year growth 2021-2026 (%)

• 7.12 Market opportunity by geography
• Exhibit 78: Market opportunity by geography ($ million)

8 Drivers, Challenges, and Trends

• 8.1 Market drivers

• 8.2 Market challenges

• 8.3 Impact of drivers and challenges
• Exhibit 79: Impact of drivers and challenges in 2021 and 2026

• 8.4 Market trends

9 Vendor Landscape

• 9.1 Overview

• 9.2 Vendor landscape
• Exhibit 80: Overview on Criticality of inputs and Factors of differentiation

• 9.3 Landscape disruption
• Exhibit 81: Overview on factors of disruption

• 9.4 Industry risks
• Exhibit 82: Impact of key risks on business

10 Vendor Analysis

• 10.1 Vendors covered
• Exhibit 83: Vendors covered

• 10.2 Market positioning of vendors
• Exhibit 84: Matrix on vendor position and classification

• 10.3 AdvaCare International
• Exhibit 85: AdvaCare International - Overview
• Exhibit 86: AdvaCare International - Product / Service
• Exhibit 87: AdvaCare International - Key offerings

• 10.4 Ardelyx Inc.
• Exhibit 88: Ardelyx Inc. - Overview
• Exhibit 89: Ardelyx Inc. - Business segments
• Exhibit 90: Ardelyx Inc. - Key news
• Exhibit 91: Ardelyx Inc. - Key offerings
• Exhibit 92: Ardelyx Inc. - Segment focus

• 10.5 AstraZeneca Plc
• Exhibit 93: AstraZeneca Plc - Overview
• Exhibit 94: AstraZeneca Plc - Product / Service
• Exhibit 95: AstraZeneca Plc - Key news
• Exhibit 96: AstraZeneca Plc - Key offerings

• 10.6 CytoSorbents Corp.
• Exhibit 97: CytoSorbents Corp. - Overview
• Exhibit 98: CytoSorbents Corp. - Business segments
• Exhibit 99: CytoSorbents Corp. - Key news
• Exhibit 100: CytoSorbents Corp. - Key offerings
• Exhibit 101: CytoSorbents Corp. - Segment focus

• 10.7 KVK Tech Inc.
• Exhibit 102: KVK Tech Inc. - Overview
• Exhibit 103: KVK Tech Inc. - Business segments
• Exhibit 104: KVK Tech Inc. - Key offerings
• Exhibit 105: KVK Tech Inc. - Segment focus

• 10.8 Sanofi SA
• Exhibit 106: Sanofi SA - Overview
• Exhibit 107: Sanofi SA - Business segments
• Exhibit 108: Sanofi SA - Key news
• Exhibit 109: Sanofi SA - Key offerings
• Exhibit 110: Sanofi SA - Segment focus

• 10.9 Steadfast MediShield Pvt. Ltd.
• Exhibit 111: Steadfast MediShield Pvt. Ltd. - Overview
• Exhibit 112: Steadfast MediShield Pvt. Ltd. - Business segments
• Exhibit 113: Steadfast MediShield Pvt. Ltd. - Key offerings
• Exhibit 114: Steadfast MediShield Pvt. Ltd. - Segment focus

• 10.10 Vifor Pharma Management Ltd.
• Exhibit 115: Vifor Pharma Management Ltd. - Overview
• Exhibit 116: Vifor Pharma Management Ltd. - Business segments
• Exhibit 117: Vifor Pharma Management Ltd. - Key news
• Exhibit 118: Vifor Pharma Management Ltd. - Key offerings
• Exhibit 119: Vifor Pharma Management Ltd. - Segment focus

11 Appendix

• 11.1 Scope of the report

• 11.2 Inclusions and exclusions checklist
• Exhibit 120: Inclusions checklist
• Exhibit 121: Exclusions checklist

• 11.3 Currency conversion rates for US$
• Exhibit 122: Currency conversion rates for US$

• 11.4 Research methodology
• Exhibit 123: Research methodology
• Exhibit 124: Validation techniques employed for market sizing
• Exhibit 125: Information sources

• 11.5 List of abbreviations
• Exhibit 126: List of abbreviations

About Us

Technavio is a leading global technology research and advisory company. Their research and analysis focus on emerging market trends and provides actionable insights to help businesses identify market opportunities and develop effective strategies to optimize their market positions. With over 500 specialized analysts, Technavio's report library consists of more than 17,000 reports and counting, covering 800 technologies, spanning across 50 countries. Their client base consists of enterprises of all sizes, including more than 100 Fortune 500 companies. This growing client base relies on Technavio's comprehensive coverage, extensive research, and actionable market insights to identify opportunities in existing and potential markets and assess their competitive positions within changing market scenarios.

Contact

Technavio Research
Jesse Maida
Media & Marketing Executive
US: +1 844 364 1100
UK: +44 203 893 3200
Email: [email protected]
Website: www.technavio.com/

SOURCE Technavio